This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Nanotech Immune Stimulant (NIS) Shows Promising Prevention Of Parahaemolyticus Vibrio Disease In Shrimp Aquaculture

DETROIT, Aug. 21, 2013 (GLOBE NEWSWIRE) -- Nano Labs Corp. (OTCQB:CTLE) is pleased to report today the results of testing of its proprietary Nanotechnology Immune Stimulant (NIS) which prevents the propagations of infections made by Vibrio Parahaemolyticus, a bacteria that cause disease in cultured shrimp.

Nano Lab's innovative solution is a Nanotech Immune Stimulant (NIS), which modulates the response of the immune system in shrimp. Tests conducted in partnership with CIBNOR, Bioassay Project No 960-0, shows the NIS increases the number of immune cells, and a considerable reduction of the proliferation rate of the bacteria.

Nano Labs and CIBNOR are pleased to report the following first round of results from the commercial pilot program.

The NIS was incorporated in the shrimp feed at various concentrations where the shrimps were fed daily at libitum up to 30 days. The daily administration of the NIS ranged in concentrations of 0 μg NIS / gram of feed (for the control tank) up to 500 μg NIS / gram of feed across six (6) treatment tanks. The treatment tanks contained three hundred (300) shrimp per tank and the mortality rate was recorded daily on the total 1,800 shrimp infected with the Parahaemolyticus Vibrio.

The percentage of shrimp survival after direct infection was 15% and 20% at 500 ug NIS / gram of feed. Further, the trials showed there is no health risk to the shrimp and the product does not affect shrimp larval development or survival.

"The laboratory preliminary numbers show promising results for shrimp at the levels tested and these dosages are effective against Parahaemolyticus Vibrio. The NIS has remarkable antibacterial activity towards the bacteria when it is incorporated in the culture media at concentrations over 10%," states Dr. Victor Castano, Chief Innovations Officer at Nano Labs. "Further tests are required that compare the effectiveness of our nanotech immune stimulant with other products available on the market as a antibacterial cocktail, as Parahaemolyticus Vibrio affects 30% of worldwide shrimp production. We are continuing to develop and test the product with the goal of achieving a 100% survival rate."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,034.93 +208.63 1.17%
S&P 500 2,100.40 +19.22 0.92%
NASDAQ 4,994.6020 +62.7870 1.27%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs